Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Comprehensive Structural Variant Detection: From Mosaic to Population-Level

PROVIDER: PRJNA953021 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR24098747_1.fastq.gz	Fastqsanger.gz
	SRR24098748_1.fastq.gz	Fastqsanger.gz
	SRR24098749_1.fastq.gz	Fastqsanger.gz
	SRR24098750_1.fastq.gz	Fastqsanger.gz
	SRR24098751_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 31

Similar Datasets

Reference Standards for Mosaic Variant Detection

Project description:Reference Standards for Mosaic Variant Detection

| PRJNA1007405 | ENA

Homo sapiens

Project description:Reference standards for mosaic variant detection

| PRJNA758606 | ENA

Reference Standards for Mosaic Variant Detection

Project description:Reference Standards for Mosaic Variant Detection

| PRJNA1007404 | ENA

Project description:Comprehensive evaluation and guidance of structural variation detection tools using population genomic data

| PRJNA943525 | ENA

Homo sapiens

Project description:Study of local assembly for structural variant detection

| PRJNA421100 | ENA

Targeted Sequencing identifies patients with pre-clinical MDS at high risk of disease progression

Project description:The diagnosis of myelodysplastic syndromes (MDS) remains problematic due to the subjective nature of morphological assessment. The reported high frequency of somatic mutations and increased structural variants by array-based cytogenetics have provided potential objective markers of disease however this has been complicated by reports of similar abnormalities in the healthy population. We aimed to identify distinguishing features between those with early MDS and reported healthy individuals by characterising 69 patients who, following a non-diagnostic marrow, developed progressive dysplasia or acute myeloid leukaemia (AML). Targeted sequencing and array based cytogenetics identified a driver mutation and/or structural variant in 91% (63/69) of pre-diagnostic samples with the mutational spectrum mirroring that in the MDS population. When compared with the reported healthy population the mutations detected had significantly greater median variant allele fraction (40% vs 9-10%) and occurred more commonly with additional mutations (≥2 mutations 64% vs. 8%). Furthermore mutational analysis identified a high-risk group of patients with shorter time to disease progression and poorer overall survival. The mutational features in our cohort are distinct from those seen in the healthy population and, even in the absence of definitive disease, can predict outcome. Early detection may allow consideration of intervention in poor risk patients.

2015-09-17 | GSE73074 | GEO

Targeted Sequencing identifies patients with pre-clinical MDS at high risk of disease progression

2015-09-17 | E-GEOD-73074 | biostudies-arrayexpress

Project description:Multiplex structural variant detection by whole-genome mapping and nanopore sequencing.

| PRJNA823696 | ENA

A novel approach for simultaneous detection of structural and single-nucleotide variants based on a combination of chromosome conformation capture and exome sequencing

Project description:Effective molecular diagnosis of congenital diseases hinges on comprehensive genomic analysis, traditionally reliant on various methodologies specific to each variant type — whole exome or genome sequencing for single nucleotide variants (SNVs), array CGH for copy-number variants (CNVs), and microscopy for structural variants (SVs). We introduce a novel, integrative approach combining exome sequencing with chromosome conformation capture, termed Exo-C. This method enables the concurrent identification of SNVs in clinically relevant genes and SVs across the genome and allows analysis of heterozygous and mosaic carriers. Enhanced with targeted long-read sequencing, Exo-C evolves into a cost-efficient solution capable of resolving complex SVs at base-pair accuracy. Through several case studies, we demonstrate how Exo-C's multifaceted application can effectively uncover diverse causative variants and elucidate disease mechanisms in patients with rare disorders.

2024-01-24 | GSE253950 | GEO

Saccharomyces cerevisiae

Project description:Structural variation detection

| PRJDB10435 | ENA